Jaguar Health, Inc. (JAGX)
4.79
+0.26
(+5.74%)
USD |
NASDAQ |
Oct 09, 16:00
4.85
+0.06
(+1.25%)
After-Hours: 20:00
Jaguar Health Profit Margin (Quarterly) : -1.05K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.05K% |
| March 31, 2026 | 43.03% |
| December 31, 2025 | -716.9% |
| September 30, 2025 | -312.9% |
| June 30, 2025 | -354.5% |
| March 31, 2025 | -478.6% |
| December 31, 2024 | -291.6% |
| September 30, 2024 | -322.4% |
| June 30, 2024 | -353.8% |
| March 31, 2024 | -398.5% |
| December 31, 2023 | -404.7% |
| September 30, 2023 | -281.0% |
| June 30, 2023 | -459.3% |
| March 31, 2023 | -628.7% |
| December 31, 2022 | -252.5% |
| September 30, 2022 | -400.3% |
| June 30, 2022 | -321.5% |
| March 31, 2022 | -692.0% |
| December 31, 2021 | -688.4% |
| September 30, 2021 | -1.94K% |
| June 30, 2021 | -3.66K% |
| March 31, 2021 | -967.7% |
| December 31, 2020 | -340.4% |
| Date | Value |
|---|---|
| September 30, 2020 | -283.7% |
| June 30, 2020 | -291.7% |
| March 31, 2020 | -913.2% |
| December 31, 2019 | -395.4% |
| September 30, 2019 | -776.6% |
| June 30, 2019 | -980.3% |
| March 31, 2019 | -522.4% |
| December 31, 2018 | -792.9% |
| September 30, 2018 | -542.2% |
| June 30, 2018 | -866.4% |
| March 31, 2018 | -708.2% |
| December 31, 2017 | -1.31K% |
| September 30, 2017 | |
| June 30, 2017 | -201.4% |
| March 31, 2017 | -573.4% |
| December 31, 2016 | -12.72K% |
| September 30, 2016 | -6.78K% |
| June 30, 2016 | -15.18K% |
| March 31, 2016 | -10.46K% |
| December 31, 2015 | -7.48K% |
| September 30, 2015 | -3.81K% |
| June 30, 2015 | -8.34K% |
| March 31, 2015 | -6.31K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Omeros Corp. | 23.26% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 21.86% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -88.88% |
| Return on Invested Capital | -131.5% |
| Gross Profit Margin (Quarterly) | -22.04% |
| Operating Margin (Quarterly) | -620.2% |
| Return on Net Operating Assets | -133.5% |